Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 3/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.31 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.31 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.31 |
| ▸ | GGH | Q92820 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27041682 | 0.81 | GGH (0.33) | FOLH1RIMKLANAALAD2GGH | |
| SCHEMBL27041677 | 0.81 | GGH (0.33) | FOLH1RIMKLANAALAD2GGH | |
| SCHEMBL20009572 | 0.74 | GNPAT (0.54) | GNPATFOLH1RIMKLANAALAD2 | |
| SCHEMBL15485862 | 0.74 | NOS2 (0.47) | — | |
| SCHEMBL28161141 | 0.74 | NOS2 (0.47) | — | |
| SCHEMBL14087200 | 0.74 | NOS2 (0.47) | — | |
| SCHEMBL14164385 | 0.74 | NOS2 (0.47) | — | |
| SCHEMBL30552373 | 0.74 | NOS2 (0.47) | — | |
| SCHEMBL20009714 | 0.73 | NOD1 (0.48) | GNPATFOLH1RIMKLANAALAD2 | |
| Hydrochloric Acid SCHEMBL21437407 | 0.72 | NOS2 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070037964-A1 | Condensation of a specifically engineered phosphine containing a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine by-product and producing an amide bond in final product | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037964-A1 | Condensation of a specifically engineered phosphine containing a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine by-product and producing an amide bond in final product | PTMS, PHOSPHO1, QPCT | GNPAT 612/4885FOLH1 169/4885RIMKLA 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.